NDAINJECTIONINJECTABLE
Approved
Dec 1981
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 8h ago · AI intelligence enriched 5d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SENSORCAINE is a local anesthetic combination product containing bupivacaine hydrochloride and epinephrine bitartrate, administered by injection for regional anesthesia and pain management. Bupivacaine is a long-acting amide local anesthetic that blocks sodium channels in nerve fibers, while epinephrine acts as a vasoconstrictor to prolong drug residence time and reduce systemic absorption. This combination is used across surgical, dental, and pain management settings for infiltration, nerve blocks, and epidural/spinal anesthesia.
LOE Approaching
Product is approaching loss of exclusivity with moderate competitive pressure (30%), suggesting the brand team is likely focused on lifecycle management, cost containment, and differentiation strategies rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on SENSORCAINE offers stability in a mature product line but limited growth upside; roles are primarily focused on defending market share, managing the transition to generics, and optimizing operational efficiency. Career advancement may be constrained compared to earlier-lifecycle products, though positions provide deep expertise in anesthetic markets and established customer relationships.
Brand Manager
Worked on SENSORCAINE at Fresenius Kabi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.